The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review

被引:42
作者
Atkinson, Thomas M. [1 ]
Andreotti, Charissa F. [1 ]
Roberts, Kailey E. [1 ]
Saracino, Rebecca M. [1 ]
Hernandez, Marisol [1 ]
Basch, Ethan [2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10022 USA
[2] Univ N Carolina, Chapel Hill, NC USA
基金
美国国家卫生研究院;
关键词
Patient outcome assessment; Health status; Neoplasms; Karnofsky performance status; QUALITY-OF-LIFE; SYMPTOM INDEX; THERAPY; SCALE; CARE; FEASIBILITY; VALIDATION; VALIDITY; CRITERIA; FATIGUE;
D O I
10.1007/s00520-015-2923-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The process of assessing patient symptoms and functionality using patient-reported outcomes (PROs) and functional performance status (FPS) is an essential aspect of patient-centered oncology research and care. However, PRO and FPS measures are often employed separately or inconsistently combined. Thus, the purpose of this study was to conduct a systematic review of the level of association between PRO and FPS measures to determine their differential or combined utility. A systematic search was conducted using five databases (1966 to February 2014) to identify studies that described an association between PRO and FPS. Studies were excluded if they were non-cancer specific, did not include adults aged 18 or older, or were review articles. Publications were selected for review by consensus among two authors, with a third author arbitrating as needed. A total of 18 studies met inclusion criteria. FPS was primarily assessed by clinicians using the ECOG Performance Status or Karnofsky Performance Status measures. PROs were captured using a variety of measures, with numerous domains assessed (e.g., pain, fatigue, and general health status). Concordance between PROs and FPS measures was widely variable, falling in the low to moderate range (0.09-0.72). Despite consistency in the method of capture of PROs or FPS, domain capture varied considerably across reviewed studies. Irrespective of the method of capturing PROs or FPS, the quantified level of association between these two areas was moderate at best, providing evidence that FPS and PRO assessments offer unique information to assist clinicians in their decision-making.
引用
收藏
页码:3645 / 3652
页数:8
相关论文
共 56 条
[1]   Palliative performance scale (PPS): A new tool [J].
Anderson, F ;
Downing, GM ;
Hill, J ;
Casorso, L ;
Lerch, N .
JOURNAL OF PALLIATIVE CARE, 1996, 12 (01) :5-11
[2]  
[Anonymous], 2010, Common terminology criteria for adverse events, v4.03
[3]  
[Anonymous], 2009, Guidance for industry: Patient-Reported outcome measures: Use in medical product development to support labeling claims
[4]  
Basch E, 2014, JNCI-J NATL CANCER I, V106, P21
[5]   Patient-Reported Outcome Performance Measures in Oncology [J].
Basch, Ethan ;
Snyder, Claire ;
McNiff, Kristen ;
Brown, Rebecca ;
Maddux, Suzanne ;
Smith, Mary Lou ;
Atkinson, Thomas M. ;
Howell, Doris ;
Chiang, Anne ;
Wood, William ;
Levitan, Nathan ;
Wu, Albert W. ;
Krzyzanowska, Monika .
JOURNAL OF ONCOLOGY PRACTICE, 2014, 10 (03) :209-211
[6]   New Frontiers in Patient-Reported Outcomes: Adverse Event Reporting, Comparative Effectiveness, and Quality Assessment [J].
Basch, Ethan .
ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 :307-317
[7]   Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology [J].
Basch, Ethan ;
Abernethy, Amy P. ;
Mullins, C. Daniel ;
Reeve, Bryce B. ;
Smith, Mary Lou ;
Coons, Stephen Joel ;
Sloan, Jeff ;
Wenzel, Keith ;
Chauhan, Cynthia ;
Eppard, Wayland ;
Frank, Elizabeth S. ;
Lipscomb, Joseph ;
Raymond, Stephen A. ;
Spencer, Merianne ;
Tunis, Sean .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34) :4249-4255
[8]   Beyond the FDA PRO Guidance: Steps toward Integrating Meaningful Patient-Reported Outcomes into Regulatory Trials and US Drug Labels [J].
Basch, Ethan .
VALUE IN HEALTH, 2012, 15 (03) :401-403
[9]   Use of Patient-Reported Outcomes to Improve the Predictive Accuracy of Clinician-Reported Adverse Events [J].
Basch, Ethan ;
Bennett, Antonia ;
Pietanza, M. Catherine .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (24) :1808-1810
[10]   The Missing Voice of Patients in Drug-Safety Reporting [J].
Basch, Ethan .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (10) :865-869